CHENG Si, ZENG Yalong, LI Hao, WANG Yongjun. Multiomics Studies Facilitate Stroke Drug Development[J]. Chinese Journal of Stroke, 2022, 17(03): 213-215.
[1] 王拥军，李子孝，谷鸿秋, 等. 中国卒中报告2019（中文版）（1）[J]. 中国卒中杂志，2020，15（10）：1037-1043.
[2] FIGTREE G A，BROADFOOT K，CASADEI B，et al. A call to action for new global approaches to cardiovascular disease drug solutions[J]. Circulation，2021，144（2）：159-169.
[3] NORRVING B. Stroke management-recent advances and residual challenges[J]. Nat Rev Neurol，2019，15（2）：69-71.
[4] VAN DIJK E L，AUGER H，JASZCZYSZYN Y，et al. Ten years of next-generation sequencing technology[J]. Trends Genet，2014，30（9）：418-426.
[5] MONTANER J，RAMIRO L，SIMATS A，et al. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke[J]. Nat Rev Neurol，2020，16（5）：247-264.
[6] MALIK R，CHAUHAN G，TRAYLOR M，et al. Multiancestry genome-wide association study of 520 000 subjects identifies 32 loci associated with stroke and stroke subtypes[J]. Nat Genet，2018，50（4）：524-537.
[7] UK10K Consortium，WALTER K，MIN J L，et al. The UK10K project identifies rare variants in health and disease[J]. Nature，2015，526（7571）：82-90.
[8] 孙泽恩，刘玉洁，欧阳倩颖，等. 组学技术在肿瘤耐药领域的研究进展：从单组学到多组学联合应用[J].中南大学学报（医学版），2021，46（6）：620-627.
[9] YOSHIDA K，MOEIN A，BITTNER T，et al. Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease[J]. Alzheimers Res Ther，2020，12（1）：16.
[10] WU S M，WU B，LIU M，et al. Stroke in China：advances and challenges in epidemiology，prevention， and management[J]. Lancet Neurol，2019，18（4）：394-405.
[11] LI Z G，LI Y L，HAN J R，et al. Formyl peptide receptor 1 signaling potentiates inf lammatory brain injury[J/OL]. Sci Transl Med，2021，13（605）：eabe9890[2021-12-01]. https://doi.org/10.1126/scitranslmed.abe9890.
[12] PLUMP A，DAVEY SMITH G. Identifying and validating new drug targets for stroke and beyond：can mendelian randomization help?[J]. Circulation，2019，140（10）：831-835.
[13] WANG Y J，JING J，MENG X，et al. The third China national st roke regist ry（CNSR-Ⅲ）for patients with acute ischaemic stroke or transient ischaemic attack：design，rationale and baseline patient characteristics[J]. Stroke Vasc Neurol，2019，4（3）：158-164.
[14] JOSHI A，RIENKS M，THEOFILATOS K，et al. Systems biology in cardiovascular disease：a multiomics approach[J]. Nat Rev Cardiol，2021，18（5）：313-330.
